922
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Nanoscience: an overview about nanotheranostics for cancer treatment

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 55-68 | Received 05 Aug 2023, Accepted 29 Dec 2023, Published online: 12 Jan 2024

References

  • Zhang Y, Li M, Gao X, et al. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019;12. doi: 10.1186/s13045-019-0833-3
  • Chaturvedi V, Singh A, Singh V, et al. Cancer nanotechnology: a new revolution for cancer diagnosis and therapy. Curr Drug Metab. 2019;20(6):416–429. doi: 10.2174/1389200219666180918111528
  • Bayda S, Adeel M, Tuccinardi T, et al. The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules. 2019;25(1):112. doi: 10.3390/molecules25010112
  • Brignole C, Pastorino F. Special issue “Recent advances in precision nanomedicine for cancer”. Molecules. 2020;25(18):4148. doi: 10.3390/molecules25184148
  • Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian J Chem. 2019;12(7):908–931. doi: 10.1016/j.arabjc.2017.05.011
  • Chavda VP, Khadela A, Shah Y, et al. Current status of cancer Nanotheranostics: emerging strategies for cancer management. Nanotheranostics. 2023;7(4):368. doi: 10.7150/ntno.82263
  • Sajjadi M, Nasrollahzadeh M, Jaleh B, et al. Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects. J Drug Targeting. 2021;29(7):716–741. doi: 10.1080/1061186X.2021.1886301
  • Kim D, Lee N, Park YI, et al. Recent advances in inorganic nanoparticle-based NIR luminescence imaging: semiconductor nanoparticles and lanthanide nanoparticles. Bioconjugate Chem. 2017;28(1):115–123. doi: 10.1021/acs.bioconjchem.6b00654
  • Singh D, Dubey P, Pradhan M, et al. Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery. Expert Opin Drug Delivery. 2013;10(2):241–259. doi: 10.1517/17425247.2012.745848
  • Aghebati‐Maleki A, Dolati S, Ahmadi M, et al. Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol. 2019;235(3):1962–1972. doi: 10.1002/jcp.29126
  • Yih TC, Al‐Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem. 2006;97(6):1184–1190. doi: 10.1002/jcb.20796
  • Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2):147–166. doi: 10.1016/j.nano.2011.05.016
  • Fan J, Cheng Y, Sun M. Functionalized gold nanoparticles: synthesis, properties and biomedical applications. Chem Rec. 2020;20(12):1474–1504.
  • Sakthi Devi R, Girigoswami A, Siddharth M, et al. Applications of gold and silver nanoparticles in theranostics. Appl Biochem Biotechnol. 2022;194(9):4187–4219. doi: 10.1007/s12010-022-03963-z
  • Ahmadi F, Sodagar-Taleghani A, Ebrahimnejad P, et al. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer. Int J Pharmaceut. 2022;625:122099. doi: 10.1016/j.ijpharm.2022.122099
  • Mathur P, Jha S, Ramteke S, et al. Pharmaceutical aspects of silver nanoparticles. Artific Cells Nanomed Biotechnol. 2018;46(sup1):115–126. doi: 10.1080/21691401.2017.1414825
  • Markwalter CF, Kantor AG, Moore CP, et al. Inorganic complexes and metal-based nanomaterials for infectious disease diagnostics. Chem Rev. 2018;119(2):1456–1518. doi: 10.1021/acs.chemrev.8b00136
  • Borel T, Sabliov CM. Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles. Annu Rev Food Sci Technol. 2014;5:197–213. doi: 10.1146/annurev-food-030713-092354
  • Bockamp E, Rosigkeit S, Siegl D, et al. Nano-enhanced cancer immunotherapy: immunology encounters nanotechnology. Cells. 2020;9(9):2102. doi: 10.3390/cells9092102
  • Baetke S, Lammers T, Kiessling F. Applications of nanoparticles for diagnosis and therapy of cancer. British J Radiol. 2015;88(1054):20150207. doi: 10.1259/bjr.20150207
  • Zhang Y, Li M, Gao X, et al. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019;12(1). doi: 10.1186/s13045-019-0833-3
  • Montané X, Bajek A, Roszkowski K, et al. Encapsulation for cancer therapy. Molecules. 2020;25(7):1605. doi: 10.3390/molecules25071605
  • Lal S, Clare S, Halas N. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res. 2008;41(12):1842–1851. doi: 10.1021/ar800150g
  • Majoros I, Ward B, Lee K, et al. Progress in cancer nanotechnology. Prog Mol Biol Transl Sci. 2010;95:193–236.
  • Saliminejad K, Khorram Khorshid H, Soleymani Fard S, et al. An overview of microRnas: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2018;234(5):5451–5465. doi: 10.1002/jcp.27486
  • Rezayi M, Farjami Z, Hosseini Z, et al. MicroRNA-based biosensors for early detection of cancers. Curr Pharm Des. 2019;24(39):4675–4680. doi: 10.2174/1381612825666190111144525
  • Sina AAI, Carrascosa LG, Trau M. DNA methylation-based point-of-care cancer detection: challenges and possibilities. Trends Mol Med. 2019;25(11):955–966. doi: 10.1016/j.molmed.2019.05.014
  • Syedmoradi L, Esmaeili F, Norton ML. Towards DNA methylation detection using biosensors. Analyst. 2016;141(21):5922–5943. doi: 10.1039/C6AN01649A
  • Dadmehr M, Hosseini M, Hosseinkhani S, et al. DNA methylation detection by a novel fluorimetric nanobiosensor for early cancer diagnosis. Biosens Bioelectron. 2014;60:35–44. doi: 10.1016/j.bios.2014.03.033
  • Klochkov SG, Neganova ME, Nikolenko VN, et al. Implications of nanotechnology for the treatment of cancer: recent advances. In: Seminars in cancer biology. Vol. 69. 2021 February. pp. 190–199.
  • Kopeckova K, Eckschlager T, Sirc J, et al. Nanodrugs used in cancer therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019;163(2):122–131. doi: 10.5507/bp.2019.010
  • Ali ES, Sharker SM, Islam MT, et al. Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives. In: Seminars in cancer biology. Vol. 69. Academic Press; 2021 February. pp. 52–68.
  • Krukiewicz K, Zak JK. Biomaterial-based regional chemotherapy: local anticancer drug delivery to enhance chemotherapy and minimize its side-effects. Mater Sci Eng C. 2016;62:927–942. doi: 10.1016/j.msec.2016.01.063
  • Halwani AA. Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14(1):106. doi: 10.3390/pharmaceutics14010106
  • Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi: 10.1038/nrc.2016.108
  • Tenchov R, Bird R, Curtze AE, et al. Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982–17015. doi: 10.1021/acsnano.1c04996
  • Farjadian F, Ghasemi A, Gohari O, et al. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93–126. doi: 10.2217/nnm-2018-0120
  • Rahamathulla M, Bhosale RR, Osmani RA, et al. Carbon nanotubes: Current perspectives on diverse applications in targeted drug delivery and therapies. Materials. 2021;14(21):6707. doi: 10.3390/ma14216707
  • Tang L, Xiao Q, Mei Y, et al. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnol. 2021;19(1):1–28. doi: 10.1186/s12951-021-01174-y
  • Sheikhpour M, Naghinejad M, Kasaeian A, et al. The applications of carbon nanotubes in the diagnosis and treatment of lung cancer: a critical review. Int J Nanomed. 2020;15:7063. doi: 10.2147/IJN.S263238
  • Mehrabian A, Mashreghi M, Dadpour S, et al. Nanocarriers call the last shot in the treatment of brain cancers. Technol Cancer Res Treat. 2022;21:15330338221080974. doi: 10.1177/15330338221080974
  • Perumal S, Atchudan R, Lee W. A review of polymeric micelles and their applications. Polymers. 2022;14(12):2510. doi: 10.3390/polym14122510
  • Glavas L, Olsén P, Odelius K, et al. Achieving micelle control through core crystallinity. Biomacromolecules. 2013;14(11):4150–4156. doi: 10.1021/bm401312j
  • Fatfat Z, Fatfat M, Gali-Muhtasib H. Micelles as potential drug delivery systems for colorectal cancer treatment. World J Gastroenterol. 2022;28(25):2867. doi: 10.3748/wjg.v28.i25.2867
  • Niculescu AG, Grumezescu AM. Novel tumor-targeting nanoparticles for cancer treatment—A review. Int J Mol Sci. 2022;23(9):5253. doi: 10.3390/ijms23095253
  • KubiakA T. Polymeric capsules and micelles as promising carriers of anticancer drugs Kapsułki i micele polimerowe jako nośniki leków przeciwnowotworowych. Polymers In Medicine. 2022;52(1):37–50. doi: 10.17219/pim/145513
  • Abdellatif AA, Younis MA, Alsharidah M, et al. Biomedical applications of quantum dots: overview, challenges, and clinical potential. Int J Nanomed. 2022;17:1951. doi: 10.2147/IJN.S357980
  • Zhang Y, Zhang Y, Han Y, et al. Micro/Nanorobots for medical diagnosis and disease treatment. Micromach. 2022;13(5):648. doi: 10.3390/mi13050648
  • Soto F, Wang J, Ahmed R, et al. Medical micro/nanorobots in precision medicine. Adv Sci. 2020;7(21):2002203. doi: 10.1002/advs.202002203
  • Zhang D, Liu S, Guan J, et al. “Motile-targeting” drug delivery platforms based on micro/nanorobots for tumor therapy. Front Bioeng Biotechnol. 2022;10. doi: 10.3389/fbioe.2022.1002171
  • Lu W, Yao J, Zhu X, et al. Nanomedicines: Redefining traditional medicine. Biomed Pharmacother. 2021;134:111103. doi: 10.1016/j.biopha.2020.111103
  • Sun L, Yu Y, Chen Z, et al. Biohybrid robotics with living cell actuation. Chem Soc Rev. 2020;49(12):4043–4069. doi: 10.1039/D0CS00120A
  • Hu Y. Self-assembly of DNA molecules: towards DNA nanorobots for biomedical applications. Cyborg And Bionic Systems. 2021;2021. doi: 10.34133/2021/9807520
  • Wang ST, Gray MA, Xuan S, et al. DNA origami protection and molecular interfacing through engineered sequence-defined peptoids. Proc Nat Acad Sci. 2020;117(12):6339–6348. doi: 10.1073/pnas.1919749117
  • Bell TH, Kaminsky LM, Gugino BK, et al. Factoring ecological, societal, and economic considerations into inoculant development. Trends Biotechnol. 2019;37(6):572–573. doi: 10.1016/j.tibtech.2019.02.009
  • Aye SL, Sato Y. Therapeutic applications of programmable DNA nanostructures. Micromach. 2022;13(2):315. doi: 10.3390/mi13020315
  • Udomprasert A, Kangsamaksin T. DNA origami applications in cancer therapy. Cancer Sci. 2017;108(8):1535–1543. doi: 10.1111/cas.13290